Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.
Nahon P, Lusivika-Nzinga C, Merle P, Zoulim F, Decaens T, Ganne-Carrié N, Pageaux GP, Leroy V, Alric L, Bronowicki JP, Bourlière M, Gournay J, Tran A, Pol S, Mathurin P, Loustaud-Ratti V, Métivier S, De Ledinghen V, Abergel A, Thabut D, D'Alteroche L, Bouattour M, Asselah T, Ouzan D, Cales P, Chazouillères O, Gelu-Simeon M, Roulot D, Boursier J, Cagnot C, Tamazirt S, Pascale A, Nilusmas S, Lewin M, Ziol M, Carrat F, Duclos-Vallée JC; ANRS CO12 CirVir, CO22 Hepather, and LICAVIR groups.
Nahon P, et al. Among authors: loustaud ratti v.
J Hepatol. 2025 Sep;83(3):701-711. doi: 10.1016/j.jhep.2025.02.008. Epub 2025 Feb 26.
J Hepatol. 2025.
PMID: 40020929